TYRA BIOSCIENCES INC (TYRA) Institutional Ownership Changes & 13F Activity
TYRA BIOSCIENCES INC (TYRA). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q1 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Fmr Llc, Vestal Point Capital, Lp, Paradigm Biocapital Advisors Lp, Price T Rowe Associates Inc, and Janus Henderson Group Plc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Ensign Peak Advisors, Inc | Buy | +74,064 | — | 74,064 | $2.84M | Q1 2026 | Aug 18, 2026 |
| Mirae Asset Global Investments Co., Ltd. | Buy | +190 | +7.3% | 2,784 | $106.63K | Q1 2026 | Aug 12, 2026 |
| Algert Global Llc | Buy | +141,140 | +301.1% | 188,010 | $7.20M | Q1 2026 | Aug 11, 2026 |
| Wells Fargo & Company/Mn | Sell | -17,377 | -59.8% | 11,672 | $447.04K | Q1 2026 | Jul 08, 2026 |
| Bank Of America Corp | Buy | +171,612 | +448.0% | 209,922 | $8.04M | Q1 2026 | May 18, 2026 |
| Arkadios Wealth Advisors | Buy | +47,567 | — | 47,567 | $1.82M | Q1 2026 | May 18, 2026 |
| California State Teachers Retirement System | Sell | -193 | -12.1% | 1,402 | $53.70K | Q1 2026 | May 18, 2026 |
| Fmr Llc | Buy | +7,735,085 | +61570.4% | 7,747,648 | $296.73M | Q1 2026 | May 15, 2026 |
| Vestal Point Capital, Lp | Sell | -2,371,000 | -97.8% | 54,000 | $2.07M | Q1 2026 | May 15, 2026 |
| Paradigm Biocapital Advisors Lp | Buy | +2,054,991 | — | 2,054,991 | $78.71M | Q1 2026 | May 15, 2026 |
| Price T Rowe Associates Inc | Buy | +971,629 | +6732.5% | 986,061 | $37.77M | Q1 2026 | May 15, 2026 |
| Janus Henderson Group Plc | Buy | +955,147 | +32.5% | 3,890,589 | $148.87M | Q1 2026 | May 15, 2026 |
| Commodore Capital Lp | Sell | -900,000 | -26.7% | 2,475,000 | $94.79M | Q1 2026 | May 15, 2026 |
| Point72 Asset Management, L.P. | Sell | -835,342 | -95.6% | 38,850 | $1.49M | Q1 2026 | May 15, 2026 |
| Barclays Plc | Buy | +757,090 | +992.1% | 833,399 | $31.92M | Q1 2026 | May 15, 2026 |
| Logos Global Management Lp | Buy | +640,000 | +304.8% | 850,000 | $32.55M | Q1 2026 | May 15, 2026 |
| Deerfield Management Company, L.P. | Buy | +549,000 | — | 549,000 | $21.03M | Q1 2026 | May 15, 2026 |
| Marshall Wace, Llp | Sell | -514,143 | -72.2% | 197,748 | $7.57M | Q1 2026 | May 15, 2026 |
| Balyasny Asset Management L.P. | Sell | -466,847 | -57.0% | 351,479 | $13.46M | Q1 2026 | May 15, 2026 |
| State Street Corp | Buy | +466,615 | +62.3% | 1,216,078 | $46.58M | Q1 2026 | May 15, 2026 |
| Goldman Sachs Group Inc | Buy | +367,947 | +201.7% | 550,334 | $21.08M | Q1 2026 | May 15, 2026 |
| Tcg Crossover Management, Llc | Buy | +350,877 | +12.1% | 3,248,980 | $124.44M | Q1 2026 | May 15, 2026 |
| Caligan Partners Lp | Buy | +332,711 | +35.2% | 1,276,968 | $48.91M | Q1 2026 | May 15, 2026 |
| Woodline Partners Lp | Buy | +301,040 | — | 301,040 | $11.53M | Q1 2026 | May 15, 2026 |
| Eversept Partners, Lp | Sell | -251,509 | -90.3% | 27,055 | $1.04M | Q1 2026 | May 15, 2026 |
| Sofinnova Investments, Inc. | Buy | +204,015 | — | 204,015 | $7.81M | Q1 2026 | May 15, 2026 |
| Stempoint Capital Lp | Buy | +193,177 | — | 193,177 | $7.40M | Q1 2026 | May 15, 2026 |
| Bvf Inc/Il | Sell | -151,469 | -7.1% | 1,976,196 | $75.69M | Q1 2026 | May 15, 2026 |
| Trexquant Investment Lp | Buy | +147,317 | — | 147,317 | $5.64M | Q1 2026 | May 15, 2026 |
| Seven Fleet Capital Management Lp | Buy | +116,125 | +146.0% | 195,685 | $7.49M | Q1 2026 | May 15, 2026 |
Frequently asked questions about TYRA activity
Which institutional owners are buying TYRA?
Institutional owners buying TYRA include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in TYRA activity?
"Buy" means an investor increased their reported position in TYRA compared to the prior reporting period. This reflects growing exposure to TYRA BIOSCIENCES INC (TYRA) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in TYRA increasing?
Institutional interest in TYRA can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related TYRA Institutional Insights
- TYRA Overview
- TYRA 13F Institutional Holders
- TYRA Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- TYRA Insider Trading & SEC Form 4 Activity
- TYRA Articles
- Top Institutional Investor Stock Rankings